Sibrotuzumab
FAP | |
|---|---|
| Clinical data | |
| ATC code |
|
| Identifiers | |
| CAS Number | |
| ChemSpider |
|
| UNII | |
  (what is this?) (verify) | |
Sibrotuzumab is a
In 2003 it failed a phase II clinical trial for metastatic colorectal cancer.[3]
References
 | This monoclonal antibody–related article is a stub. You can help Wikipedia by expanding it. |